Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

BET, SRC, and BCL2 Family Inhibitors Are Synergistic Drug Combinations with PARP Inhibitors in Ovarian Cancer

Goldie Y. L. Lui,Reid Shaw,Franz X. Schaub,Isabella N. Stork,Kay E. Gurley,Caroline Bridgwater,Robert L. Diaz,Rachele Rosati,Hallie A. Swan,Tan A. Ince,Thomas C. Harding,Vijayakrishna K. Gadi,Barbara A. Goff,Christopher J. Kemp,Elizabeth M. Swisher,Carla Grandori

EBioMedicine（2020）

Cited 22|Views54

Key words

Ovarian cancer,Drug combinations,Poly(ADP-ribose) Polymerase Inhibitors,Rucaparib,Dasatinib,Navitoclax

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined